Jeff Macdonald

Investor Relations Kontakt på JAZZ PHARMACEUTICALS PLC

Health Technology

Consumer Services

Profil

Jeff Macdonald is currently Executive Director-Investor Relations at Jazz Pharmaceuticals Plc and will hold the same title at Vaxcyte, Inc. starting in 2025.
Former roles include Senior Director-Corporate Communications at Acorda Therapeutics, Inc. and Senior Director-Investor Relations at G1 Therapeutics, Inc. from 2018 to 2021.
Education includes an undergraduate degree from Washington & Lee University.

Aktiva positioner av Jeff Macdonald

Företag	Position	Start
JAZZ PHARMACEUTICALS PLC	Investor Relations Kontakt	-
VAXCYTE, INC.	Investor Relations Kontakt	2025-06-01

Alla aktiva positioner av Jeff Macdonald

Tidigare kända positioner av Jeff Macdonald

Företag	Position	Slut
G1 THERAPEUTICS, INC.	Investor Relations Kontakt	2021-01-04
ACORDA THERAPEUTICS, INC.	Investor Relations Kontakt	2012-05-10

Se detaljerna i Jeff Macdonalds erfarenhet

Jeff Macdonalds utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Jeff Macdonalds erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies	Health Technology
Washington & Lee University Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Jazz Pharmaceuticals Plc Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders	Health Technology
G1 Therapeutics, Inc. G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment	Health Technology
Vaxcyte, Inc. Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases	Health Technology